Effect of Intraoperative Nefopam on Acute Pain After Remifentanil Based Anesthesia
Brief Summary
Many anesthesiologists use the Remifentanil for reducing a surgical pain and stabilizing a vital sign. However, this drug induce postoperative hyperalgesia. Nowadays, many studies report that low-dose Ketamine prevents the opioid-induces hyperalgesia. Nefopam, which is non-opioid analgesic, has similar mechanism with Ketamine. It will be helpful for postoperative pain control, and reduce the needs of opioid.
Condition or Disease
- Cholecystitis
Phase
Study Design
| Study type: | Interventional |
|---|---|
| Status: | Unknown status |
| Study results: | No Results Available |
| Age: | 20 Years to 65 Years (Adult, Older Adult) |
| Enrollment: | 60 () |
| Funded by: | Other |
Masking |
|
Clinical Trial Dates
| Start date: | Mar 15, 2020 | |
|---|---|---|
| Primary Completion: | Dec 15, 2020 | |
| Completion Date: | Aug 31, 2020 | |
| Study First Posted: | Jul 09, 2015 | |
| Results First Posted: | Aug 31, 2020 | |
| Last Updated: | Sep 02, 2015 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Location
Eligibility Criteria
| Sex: | All |
|---|---|
| Minimum Age: | 20 |
| Maximum Age: | 65 |
More Details
| NCT Number: | NCT02493231 |
|---|---|
| Other IDs: | 2014-10-133 |
| Study URL: | https://ClinicalTrials.gov/show/NCT02493231 |
Last updated: Jan 27, 2021